Retatrutide (GGG Tri-agonist, LY3437943) is a novel research peptide with potential applications in metabolic disorder studies. As a GLP-1/GIP/glucagon tri-agonist, it demonstrates enhanced efficacy compared to single-agonist compounds in preliminary research models.
This peptide may be of interest for researchers investigating:
- Mechanisms of weight regulation
- Glucose metabolism pathways
- Potential therapeutic approaches for metabolic syndrome
- Comparative studies with other metabolic peptides
The product is supplied as a lyophilized powder in sterile vials, suitable for research purposes only. Each batch undergoes rigorous quality control testing to ensure purity and consistency.
Storage: Maintain at -20°C for long-term stability. For immediate use, store at 2-8°C. Protect from light and moisture.
Note: This product is intended for laboratory research use only. Not for human consumption.